Literature DB >> 17652229

FDA legislation.

Michael Givel1.   

Abstract

Mesh：

Year:  2007        PMID： 17652229      PMCID： PMC2598532          DOI： 10.1136/tc.2007.021931

Source DB:  PubMed          Journal:  Tob Control        ISSN： 0964-4563            Impact factor:   7.552


× No keyword cloud information.
  5 in total

1.  The "global settlement" with the tobacco industry: 6 years later.

Authors:  Michael Givel; Stanton A Glantz
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

2.  Philip Morris' FDA gambit: good for public health?

Authors:  Michael Givel
Journal:  J Public Health Policy       Date:  2005-12       Impact factor: 2.222

Review 3.  Philip Morris's Project Sunrise: weakening tobacco control by working with it.

Authors:  P A McDaniel; E A Smith; R E Malone
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

4.  Calculated cancer risks for conventional and "potentially reduced exposure product" cigarettes.

Authors:  James F Pankow; Karen H Watanabe; Patricia L Toccalino; Wentai Luo; Donald F Austin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

5.  Understanding Philip Morris's pursuit of US government regulation of tobacco.

Authors:  P A McDaniel; R E Malone
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552
  5 in total
  1 in total

1.  Policy coherence in US tobacco control: beyond FDA regulation.

Authors:  Joshua S Yang; Thomas E Novotny
Journal:  PLoS Med       Date:  2009-05-19       Impact factor: 11.069
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.